Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,6R,9S,12S,15S,18S,21S,24S,27S,30R,35R,38S,41S,46aS,49R)-41-((1H-imidazol-5-yl)methyl)-15,18-bis(2-amino-2-oxoethyl)-21-(3-amino-3-oxopropyl)-49-(2-(2-aminoacetamido)acetamido)-24-(carboxymethyl)-27-(4-hydroxybenzyl)-38-(hydroxymethyl)-3,9,12-trimethyl-1,4,7,10,13,16,19,22,25,28,36,39,42,48-tetradecaoxodotetracontahydro-1H,34H-35,6-(epiminopropanodithiomethano)pyrrolo[2,1-h1][1,2]dithia[5,8,11,14,17,20,23,26,29,32,35,38,41]tridecaazacyclotetratetracontine-30-carboxylic acid
ID: ALA5178812
PubChem CID: 168274236
Max Phase: Preclinical
Molecular Formula: C65H92N22O25S4
Molecular Weight: 1709.85
Associated Items: